- Home
- / Protalix BioTherapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Protalix BioTherapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₪7.3
2023-03-20
Market Capitalization
₪420.3 M
2023-03-20
Revenue
$52.7 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 34.2M | 54.7M | 62.9M | 38.4M | 47.6M | 65.5M | 53.4M | 52.7M |
| Cost of goods sold | 7.6M | 9.3M | 9.6M | 15.2M | 18.5M | 21.8M | 23.0M | 25.5M |
| Gross profit | 26.6M | 45.4M | 53.3M | 23.1M | 29.1M | 43.7M | 30.4M | 27.2M |
| Gross profit margin, % | 77.7% | 83.0% | 84.8% | 60.3% | 61.2% | 66.7% | 56.9% | 51.6% |
| Operating expense total | 44.2M | 54.5M | 49.3M | 42.5M | 41.1M | 32.1M | 25.2M | 31.3M |
| Depreciation and amortization | 1.7M | 1.6M | 1.3M | 1.1M | 1.1M | 1.2M | 1.3M | 1.5M |
| EBITDA | (17.6M) | (9.1M) | 4.0M | (19.3M) | (11.9M) | 11.7M | 5.2M | (4.0M) |
| EBITDA margin, % | -51.5% | -16.6% | 6.4% | -50.4% | -25.0% | 17.8% | 9.8% | -7.7% |
| EBIT | (19.3M) | (10.7M) | 2.7M | (20.5M) | (13.0M) | 10.5M | 3.9M | (5.5M) |
| EBIT margin, % | -56.4% | -19.6% | 4.3% | -53.4% | -27.3% | 16.0% | 7.3% | -10.4% |
| Interest income | 536.0K | 407.0K | 438.0K | 401.0K | 1.1M | 1.3M | 1.3M | 1.1M |
| Interest expense | 7.7M | 8.0M | 9.7M | 7.5M | 2.5M | 3.2M | 1.1M | 1.2M |
| Pre tax profit | (26.5M) | (18.3M) | (6.5M) | (27.6M) | (14.4M) | 8.6M | 4.2M | (5.6M) |
| Income tax expense | 530.0K | 254.0K | 1.2M | 996.0K | ||||
| Net Income | (26.5M) | (18.3M) | (6.5M) | (27.6M) | (14.9M) | 8.3M | 2.9M | (6.6M) |